Skip to main content
Glama

Missouri License Offices

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.5/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, openWorldHint, idempotentHint, and destructiveHint=false. The description adds substantial non-obvious behavior: identifiers are labelled with their source, unresolvable identifiers are exposed under `unresolved` rather than omitted, LEI/FIGI enrichment degrades gracefully, and each call cascades through multiple endpoints. It also documents ISIN-to-LEI resolution and that non-equity instruments without tickers still resolve. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness3/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is information-dense but poorly structured—the 'company' type is a long run-on parenthetical mixing input formats, output fields, and edge cases into one complex clause. It is front-loaded with purpose and usage, and length is arguably justified by complexity, but the organization would be far clearer with bullet points or separate sentences for each concern.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

There is no output schema, so the description bears full responsibility for explaining return values—and it does. It enumerates returned identifiers (CIK, ticker, company_name, LEI with ownership, FIGI, RxCUI/ingredient/brand/citation), describes the `unresolved` field, covers graceful degradation, and gives input constraints. An agent has enough context to select and invoke the tool correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so the baseline is 3. The description adds real parameter meaning beyond the schema: it states that `value` for company accepts ticker, CIK, ISIN, or company name (ISIN is not mentioned in the schema), explains the exact-ticker vs name-search resolution path, and clarifies that non-equity instruments without tickers still resolve. This adds semantic value for an agent choosing what to pass.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a specific verb-resource pair: 'resolve a user-spoken NAME to the canonical/official identifiers other tools require as input.' It lists example user queries and explicitly positions itself as the name-to-ID tool, distinguishing it from siblings that consume those IDs. This is more than a vague statement—it tells an agent exactly what job the tool performs.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives an explicit trigger condition: 'Use FIRST whenever you have a name but need an ID.' It also reinforces this with 'using resolve_entity replaces 2-3 manual lookups.' However, it does not name specific alternatives or state when not to use it, so the guidance is clear but lacks explicit exclusions.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.9/5.0
Disambiguation1/5

Multiple tools overlap heavily: ask_pipeworx, ask_pipeworx_beta (explicitly identical today), ask_pipeworx_grounded, deep_research, validate_claim, and discover_tools all route natural-language data questions, while entity_profile, recent_changes, compare_entities, and resolve_entity overlap around company data. An agent cannot reliably distinguish which retrieval entry point to choose.

Naming Consistency4/5

Tool names are almost uniformly lowercase snake_case and mostly follow a recognizable verb_noun or domain-prefixed pattern (ask_pipeworx*, polymarket_*, pipeworx_*, scan_*, recent_*, subscribe/unsubscribe). A few names like deep_research, entity_profile, and bet_research break the verb-first style, but there is no chaotic convention mixing.

Tool Count2/5

32 tools is too many for the apparent scope, and more importantly only one tool (mo_dmv_license_offices) matches the server name 'Missouri License Offices.' The other 31 tools form a general data-research, prediction-market, memory, and subscription platform that has little to do with the stated purpose.

Completeness4/5

Judged as the broad Pipeworx-style research platform the descriptions reveal, the surface is quite complete: simple and grounded querying, deep multi-source research, claim verification, entity resolution, profiles, comparisons, change feeds, discovery, subscriptions, alerts, and memory. For the literal Missouri license-office purpose, however, only the single lookup tool is present, which drags down completeness despite that tool being reasonably thorough.